Please login to the form below

Opinion piece: Personalisation – the future of medical education

Alex Goonesinghe, Research Manager, and Nigel Campbell, Multichannel Communications Director, share their thoughts on the growing trend towards personalised medical education.

In this article Alex and Nigel discuss the importance of understanding audience groups through persona development, which will enable you to communicate with these segments better based on their information needs, frequency of contact and channel preferences.  

You can read the full article, originally published in PharmaFocus, here.  

Below is an example of a persona we’ve developed for an ‘engaged prescriber’.


If you would like to speak to Alex or Nigel about personalised medical education they can be contacted on or  

This article was published by Ashfield Healthcare Communications, part of UDG Healthcare plc.

10th November 2016



Company Details


Contact Website

Ashfield House
Resolution Road
Ashby de la Zouch
LE65 1HW

Latest content on this profile

Ashfield wins Best Newcomer at the Pf Awards 2018
We are thrilled to announce that Zuchaela Smylie, from Ashfield, won Best Newcomer at the 2018 Pf Awards, the largest pharmaceutical sales awards in the UK. The awards ceremony took place on Thursday, 9 March at The Lancaster Hotel in London.
“It is evident that meeting face-to-face is still highly valued in the digital age”
Attending a scientific congress or meeting overtakes professional journals and publications as the educational channel of choice for Healthcare Professionals – according to findings of new study
Ashfield to present at the Orphan Drugs for Rare Diseases Summit
Ashfield has a breadth of experience with orphan drugs and we are passionate about helping to improve the lives of people living with rare diseases. We are delighted to be sponsoring and presenting at the ‘Orphan Drugs for Rare Diseases’ event 22-23 March in Berlin.
Addressing the biggest challenges for rare disease communities
Each year, Rare Disease Day takes place worldwide on the last day in February. The main objective of Rare Disease Day is to raise awareness amongst the general public, the healthcare industry and decision-makers about rare diseases and their impact on patients' lives.
Humanise is our strategic approach to healthcare communications. It’s based on the need to understand. It looks at the emotions that make us human. It examines the feelings we have as individuals. It defines the behaviours we show as people.
Ashfield launches new commercial model to improve ROI
Ashfield, part of UDG Healthcare, a global leader in providing outsourced healthcare services, has announced the launch of a pioneering new commercial model called The Ashfield Solution.